Find Grants for Higher Education

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

Total Dollars Available
$ 100 Trillion

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-059

Agency: National Institutes of Health

Open Date: October 22, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

Deadline: October 15, 2027


Opportunity Number: PAR-25-120

Agency: National Institutes of Health

Open Date: October 18, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.173

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-25-074

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-25-075

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-062

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-098

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.307, 93.121, 93.313

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-24-304

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Occupational Safety and Health Education and Research Centers (T42)

Deadline: October 26, 2028


Opportunity Number: RFA-OH-25-002

Agency: Centers for Disease Control and Prevention - ERA

Open Date: October 7, 2024

Close Date: October 26, 2028

Status: Posted

CFDA Numbers: 93.262

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PA-25-093

Agency: National Institutes of Health

Open Date: October 4, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855, 93.846

Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)

Deadline: September 29, 2027


Opportunity Number: PAR-25-020

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: September 29, 2027

Status: Posted

CFDA Numbers: 93.173

SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY

Deadline: September 29, 2029


Opportunity Number: DE-FOA-0003467

Agency: Advanced Research Projects Agency Energy

Open Date: October 2, 2024

Close Date: September 29, 2029

Status: Posted

CFDA Numbers: 81.135

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2027


Opportunity Number: PAR-24-293

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: August 18, 2027

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866

Fundamental Research to Counter Weapons of Mass Destruction

Deadline: September 30, 2034


Opportunity Number: HDTRA1-25-S-0001

Agency: Defense Threat Reduction Agency

Open Date: October 1, 2024

Close Date: September 30, 2034

Status: Posted

CFDA Numbers: 12.351

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PA-25-080

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.394, 93.867, 93.273, 93.859, 93.121, 93.310, 93.350, 93.853, 93.855, 93.233, 93.395, 93.837, 93.279, 93.393, 93.213, 93.172, 93.113, 93.846, 93.866, 93.838, 93.879, 93.839, 93.286, 93.399, 93.361, 93.242, 93.396, 93.840

Atmosphere Cluster

No deadline specified


Opportunity Number: PD-24-7790

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

Geospace Cluster

No deadline specified


Opportunity Number: PD-24-7789

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

Infrastructure Cluster

No deadline specified


Opportunity Number: PD-24-7791

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Deadline: June 15, 2027


Opportunity Number: RFA-MH-26-120

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: June 15, 2027

Status: Posted

CFDA Numbers: 93.213, 93.867, 93.853, 93.286, 93.865, 93.242, 93.279, 93.273, 93.866, 93.173

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2026


Opportunity Number: PAR-25-051

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: August 18, 2026

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.853, 93.242, 93.273, 93.213, 93.866

NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)

Deadline: September 25, 2027


Opportunity Number: PAR-24-301

Agency: National Institutes of Health

Open Date: September 24, 2024

Close Date: September 25, 2027

Status: Posted

CFDA Numbers: 93.865

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Deadline: January 15, 2027


Opportunity Number: RFA-NS-25-023

Agency: National Institutes of Health

Open Date: September 18, 2024

Close Date: January 15, 2027

Status: Posted

CFDA Numbers: 93.846, 93.121, 93.213, 93.273, 93.847, 93.865, 93.393, 93.866, 93.853, 93.867

Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-24-297

Agency: National Institutes of Health

Open Date: September 17, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279

Multilateral Partnerships Leveraging Excellence

No deadline specified


Opportunity Number: PD-24-7298

Agency: U.S. National Science Foundation

Open Date: September 14, 2024

Status: Posted

CFDA Numbers: 47.079

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-043

Agency: National Institutes of Health

Open Date: September 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393, 93.396

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-044

Agency: National Institutes of Health

Open Date: September 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.396, 93.399

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.